Alcohol and smoking habits in association with hepatocellular carcinoma risk
Cotinine
DOI:
10.1002/ijc.35401
Publication Date:
2025-03-18T07:20:26Z
AUTHORS (38)
ABSTRACT
Abstract We assessed hepatocellular carcinoma (HCC) risk associated with smoking and alcohol consumption their interactions, using both questionnaire data objective serum biomarkers. Information on was collected at baseline from 450,112 participants of the EPIC cohort, among whom 255 developed HCC after a median follow‐up 14 years. In nested case–control subset 108 cases matched controls, known biomarkers (cotinine, nicotine) habitual (2‐hydroxy‐3‐methylbutyric acid) were annotated untargeted metabolomics features. Multivariable‐adjusted hazard ratios (HRs) or odds (ORs) 95% confidence intervals (CIs) computed, multiplicative additive interaction parameters calculated. Compared to never smokers, current smokers had higher (HR = 2.46, CI 1.77–3.43) dose‐dependently number cigarettes smoked per day ( P trend <.001). light drinkers, in former 3.20, 1.70–6.03), periodically heavy 1.98, 1.11–3.54), always 5.51, 2.39–12.7) drinkers. Higher also observed highest versus lowest tertiles cotinine (OR 4.88, 1.52–15.70), nicotine 5.80, 1.33–25.30) 2‐hydroxy‐3‐methylbutyric acid 5.89, 1.33–26.12). Questionnaire‐assessed exposures did not demonstrate an (MI 0.88, 0.40–1.96) (RERI 0.71, −10.1 23.6; attributable proportion 0.17, −0.52 1.16; synergy index 1.27, 0.98–1.66) scales. Similar analyses cotinine, nicotine, show interactions between risk. Smoking are strong independent factors for do appear synergistically impact its risk, but larger studies needed.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (49)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....